Insights

Professional
Practice
Industry
Region
Trending Topics
Location
Type

Sort by:

Firm News 1 result

Firm News | 1 min read | 08.19.25

Crowell & Moring Represents Halda Therapeutics in Landmark Alliance With VantAI To Discover Next-Generation RIPTAC Medicines

New York – August 19, 2025: Crowell & Moring represented Halda Therapeutics in a strategic research collaboration, worth over $1 billion in total potential value, with VantAI to discover next-generation RIPTAC (Regulated Induced Proximity Targeting Chimeras) medicines.
...